Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Battaglin

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Oncogene|July 4, 2025
Pan-RAS inhibitors and polo-like kinase 1: promising targets in colorectal cancerPriya Jayachandran, Andrew Elliott, Shivani Soni, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Targeting circadian transcriptional programs through a cis-regulatory mechanism in triple negative breast cancerYuanzhong Pan, Tsu-Pei Chiu, Lili Zhou, et al.
Scientific Reports|June 10, 2021
Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patientsMadiha Naseem, Shu Cao, Dongyun Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2024
<i>HER2</i> Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405Francesca Battaglin, Fang-Shu Ou, Xueping Qu, et al.
Clinical Colorectal Cancer|October 9, 2018
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based ChemotherapyRyuma Tokunaga, Shu Cao, Madiha Naseem, et al.
Oncogene|October 1, 2022
Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatmentFrancesca Battaglin, Priya Jayachandran, Carly Strelez, et al.
International Journal of Molecular Sciences|March 27, 2025
Genetic Polymorphisms in MHC Classes I and II Predict Outcomes in Metastatic Colorectal CancerPooja Mittal, Francesca Battaglin, Yan Yang, et al.
Journal for Immunotherapy of Cancer|November 11, 2020
Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancerHiroyuki Arai, Yi Xiao, Fotios Loupakis, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2022
Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trialsJingyuan Wang, Yi Xiao, Fotios Loupakis, et al.
Molecular Cancer Therapeutics|March 31, 2021
RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICCHiroyuki Arai, Shu Cao, Francesca Battaglin, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Oncogene|July 4, 2025
Pan-RAS inhibitors and polo-like kinase 1: promising targets in colorectal cancerPriya Jayachandran, Andrew Elliott, Shivani Soni, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Targeting circadian transcriptional programs through a cis-regulatory mechanism in triple negative breast cancerYuanzhong Pan, Tsu-Pei Chiu, Lili Zhou, et al.
Scientific Reports|June 10, 2021
Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patientsMadiha Naseem, Shu Cao, Dongyun Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2024
<i>HER2</i> Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405Francesca Battaglin, Fang-Shu Ou, Xueping Qu, et al.
Clinical Colorectal Cancer|October 9, 2018
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based ChemotherapyRyuma Tokunaga, Shu Cao, Madiha Naseem, et al.
Oncogene|October 1, 2022
Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatmentFrancesca Battaglin, Priya Jayachandran, Carly Strelez, et al.
International Journal of Molecular Sciences|March 27, 2025
Genetic Polymorphisms in MHC Classes I and II Predict Outcomes in Metastatic Colorectal CancerPooja Mittal, Francesca Battaglin, Yan Yang, et al.
Journal for Immunotherapy of Cancer|November 11, 2020
Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancerHiroyuki Arai, Yi Xiao, Fotios Loupakis, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2022
Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trialsJingyuan Wang, Yi Xiao, Fotios Loupakis, et al.
Molecular Cancer Therapeutics|March 31, 2021
RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICCHiroyuki Arai, Shu Cao, Francesca Battaglin, et al.
Pageof 9